Akari Therapeutics Plc (AKTX)
Akari Therapeutics Market Cap: 10.33M for Dec. 31, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| DBV Technologies SA | 524.53M |
| Ascendis Pharma A/S | 13.03B |
| Cellectis SA | 485.57M |
| Biodexa Pharmaceuticals Plc | 1.904M |
| NuCana Plc | 14.98M |
Market Cap Related Metrics
| Price to Book Value | 0.4553 |
| Price | 0.289 |
| Earnings Yield | -135.4% |